Krka to pay €2.8 million damages to Lilly
This article was originally published in Scrip
Executive Summary
Krka will pay Lilly €2.8 million in damages for selling Zalasta, its generic olanzapine (Lilly's atypical antipsychotic Zyprexa), in Germany.